Implementing demand & operations planning in clinical cell & gene therapy

The speed of breakthroughs in cell and gene therapy has resulted in explosive growth, presenting new challenges in the clinical trial supply chain. This rapid growth has exposed challenges that can disrupt the demand-supply cycle. The emerging cell and gene therapy industry will require significant changes through the implementation of proven processes that have resulted in supply chain innovation. One of these key proven business processes is demand and operations planning (D&OP). Companies that have implemented a D&OP process have seen drastic improvements in managing their demand–supply cycle. As successful as the D&OP process has been for many industries, it has traditionally been associated with large biopharma rather than small-medium sized CGT’s clinical stage companies. This has created a slow adoption rate in CGT. This article explains how D&OPs can be implemented in a clinical CGT environment and why it’s important in implementing this process.

Please enter your email to access content Read now